My job depends on NIH continuing to function, but it is not immediately clear that this particular decision follows other worrying trends...
My job depends on NIH continuing to function, but it is not immediately clear that this particular decision follows other worrying trends discussed here previously. Removing K-awards for clinical trials (but not regular, cheaper study formats) might simply be a recognition that clinical trials are too expensive for the K-format and conducting underpowered clinical trials does not help anyone much.
Posted by SubiculumCode on Aug 16, 2026, 8:37 PM
Tags
Related issues
- Yeah, the plan is far too expensive for what it provides.
- Crashed demand after one of the big AI labs (probably Anthropic because they focus way too hard on expensive frontier models) become inso...
- /dev/random is much too expensive for this.
- Yeah, this always bugged me.
- A year ago, I had the opinion that it'd be too expensive for developers to support offline mode, peer to peer, or community servers after...
- The weird thing about this product is that its biggest competitor is "an old ipad." I feel like most of their target customer base alread...
Raise real-world problems, find people facing the same issue, and discuss solutions.2,000 issues0 comments
pricing (Other)
Yeah, the plan is far too expensive for what it provides.
NewCrashed demand after one of the big AI labs (probably Anthropic because they focus way too hard on expensive frontier models) become inso...
New/dev/random is much too expensive for this.
Yeah, this always bugged me.
A year ago, I had the opinion that it'd be too expensive for developers to support offline mode, peer to peer, or community servers after...
The weird thing about this product is that its biggest competitor is "an old ipad." I feel like most of their target customer base alread...
There's a talk from Travis Kalanick recently on a podcast about this.
>nobody ever bought German cars for their low prices, except the Beetle Huh?
My job depends on NIH continuing to function, but it is not immediately clear that this particular decision follows other worrying trends...
My job depends on NIH continuing to function, but it is not immediately clear that this particular decision follows other worrying trends discussed here previously. Removing K-awards for clinical trials (but not regular, cheaper study formats) might simply be a recognition that clinical trials are too expensive for the K-format and conducting underpowered clinical trials does not help anyone much.
Comments (0)
No comments yet. Start the discussion.